scholarly journals Therapeutic Management: When and What

Migraine ◽  
2020 ◽  
Author(s):  
Theodoros Mavridis ◽  
Marianthi Breza ◽  
Christina I. Deligianni ◽  
Dimos D. Mitsikostas
Keyword(s):  
Treatment Options ◽  
Symptomatic Therapy ◽  
Dietary Interventions ◽  
Non Invasive ◽  
The Third ◽  
Life Threatening ◽  
Behavioral Therapies ◽  
Cognitive Behavioral Therapies ◽  
Drug Overuse ◽  
Disease Specific

Migraine is a widespread brain disease that is classified as the second most disabling condition and has the third highest prevalence of all medical conditions. Despite its non-emergent or life-threatening nature, migraine can progress to chronic type, a subform associated with significant morbidity and drug overuse. In the management of migraine, it is important therefore to introduce early prophylactic treatment in order to limit migraine chronification. In this chapter, we will go through all the treatment options, both acute and preventive, pharmaceutical and non-pharmaceutical following this flowchart: 1. Introduction; 2. General principles; 2.1 Symptomatic therapy; 2.2 Prophylactic management; 3. Pharmaceutical therapies; 3.1 Symptomatic; 3.1.1 Disease-specific; 3.1.2 No disease-specific; 3.2 Prophylactic; 3.2.1 Disease-specific; 3.2.2 No disease-specific; 3.3 Non-Pharmaceutical therapies; 3.4 Neuromodulation; 3.4.1 Invasive; 3.4.5 Non-invasive; 3.5 Nutrient (nutraceuticals); 3.6 Dietary interventions; 3.7 Acupuncture; 3.8 Physical therapy; 4. Cognitive behavioral therapies; 5. Patient centricity and patient education.

Conventional versus Mindfulness-based Interventions for Anxiety and Worry: A Review and Recommendations

2020 ◽  
Vol 16 (1) ◽  
pp. 60-67
Author(s):  
Deah Jo Abbott ◽  
Caleb Wayne Lack
Keyword(s):  
Treatment Options ◽  
Additional Treatment ◽  
Third Wave ◽  
Stage Model ◽  
Pharmacological Treatments ◽  
The Past ◽  
Behavioral Therapies ◽  
Cognitive Behavioral Therapies ◽  
Specific Disorders ◽  
Psychiatric Problems

Anxiety disorders are among the most prevalent and most functionally impairing psychiatric problems experienced by the population. Both pharmacological and psychological evidencebased treatments exist for a number of specific disorders, but may fail to fully relieve symptoms, pointing to the need for additional treatment options. Often considered to be part of the “third wave” of cognitive-behavioral therapies, treatments incorporating mindfulness have emerged in the past two decades as increasingly popular with clinicians and frequently sought out by consumers. The present article reviews the extant literature regarding the efficacy and effectiveness of mindfulnessbased treatments for anxiety, worry, and related problems. Although they have not attained the solid empirical status of CBT or certain pharmacological treatments, the extant research shows mindfulness- based interventions appear to be a promising and useful treatment for people suffering from anxiety and worry. Further work should be done, levels 3-5 of the NIH stage model to determine whether or not they should be further implemented.

Acceptance and Mindfulness-Based Interventions

2016 ◽  
pp. 434-446
Author(s):  
Robert Zettle ◽  
Suzanne Gird
Keyword(s):  
Acceptance And Commitment Therapy ◽  
Randomized Clinical Trials ◽  
Empirical Support ◽  
Mechanisms Of Action ◽  
Process Variables ◽  
The Third ◽  
Treatment And Prevention ◽  
Acceptance And Commitment ◽  
Behavioral Therapies ◽  
Cognitive Behavioral Therapies

Acceptance and mindfulness-based interventions are part of the third generation of cognitive–behavioral therapies (Hayes, 2004). Among these approaches, acceptance and commitment therapy (ACT) and mindfulness-based cognitive therapy (MBCT) enjoy the greatest empirical support in the treatment and prevention of depression. Despite some similarities, ACT and MBCT differ on philosophical, methodological, and strategic dimensions. Outcome literature is more extensive for MBCT; empirical support for putative therapeutic processes specific to each appears to be stronger for ACT. Increasingly both approaches have been extended into clinical areas previously occupied by the other, with ACT being used for prevention of depression and MBCT for treatment of acute depressive symptoms. These developments have made it possible to indirectly compare their therapeutic impact and suggest shared mechanisms of action. Randomized clinical trials in which ACT and MBCT are directly evaluated on common outcome and process variables are recommended to more fully explicate these comparisons.

scholarly journals Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review

CJEM ◽  
2007 ◽  
Vol 9 (04) ◽  
pp. 304-308 ◽  
Author(s):  
Kristopher Wiebe ◽  
Brian H. Rowe
Keyword(s):  
Mechanical Ventilation ◽  
Case Report ◽  
Acute Asthma ◽  
Treatment Options ◽  
Non Invasive ◽  
Systemic Corticosteroids ◽  
Severe Asthmatic ◽  
Nebulized Salbutamol ◽  
Life Threatening ◽  
Severe Acute Asthma

ABSTRACT Acute asthma is a common emergency department (ED) problem that is typically treated with bronchodilators and anti-inflammatories. Nebulized selective, short-acting β-agonists, such as salbutamol, are the bronchodilators of choice in most Canadian EDs. Other important treatments in moderate-to-severe cases include systemic corticosteroids and in severe cases may include the addition of ipratropium bromide and magnesium sulfate. Despite aggressive management, some patients do not respond adequately to nebulized salbutamol. Treatment options in these patients are limited to interventions such as parenteral epinephrine, and non-invasive and mechanical ventilation (or both). Both parenteral epinephrine and mechanical ventilation have associated risks, so alternative treatments with a lower risk profile would be useful for the treatment of life-threatening asthma. The following case report describes a patient in whom nebulized racemic epinephrine was used successfully to treat severe acute asthma following failure of standard first-line therapies.

scholarly journals Considerations for Pairing Cognitive Behavioral Therapies and Non-invasive Brain Stimulation: Ignore at Your Own Risk

2021 ◽  
Vol 12 ◽  
Author(s):  
Christine A. Conelea ◽  
Suma Jacob ◽  
A. David Redish ◽  
Ian S. Ramsay
Keyword(s):  
Brain Stimulation ◽  
Critical Time ◽  
Careful Consideration ◽  
Cognitive Behavioral ◽  
Brain State ◽  
Non Invasive ◽  
Synergistic Activation ◽  
Behavioral Therapies ◽  
Cognitive Behavioral Therapies ◽  
Methodological Considerations

Multimodal approaches combining cognitive behavioral therapies (CBT) with non-invasive brain stimulation (NIBS) hold promise for improving the treatment of neuropsychiatric disorders. As this is a relatively new approach, it is a critical time to identify guiding principles and methodological considerations to enhance research rigor. In the current paper, we argue for a principled approach to CBT and NIBS pairings based on synergistic activation of neural circuits and identify key considerations about CBT that may influence pairing with NIBS. Careful consideration of brain-state interactions and CBT-related nuances will increase the potential for these combinations to be positively synergistic.

An Overview of Dementias

2012 ◽  
Vol 21 (3) ◽  
pp. 75-84
Author(s):  
Venkata Vijaya K. Dalai ◽  
Jason E. Childress ◽  
Paul E Schulz
Keyword(s):  
Clinical Presentation ◽  
Treatment Options ◽  
Current Treatment ◽  
Great Variability ◽  
Health Concern ◽  
Public Health Concern ◽  
Life Threatening ◽  
The Common ◽  
Neurodegenerative Dementias ◽  
Made In

Dementia is a major public health concern that afflicts an estimated 24.3 million people worldwide. Great strides are being made in order to better diagnose, prevent, and treat these disorders. Dementia is associated with multiple complications, some of which can be life-threatening, such as dysphagia. There is great variability between dementias in terms of when dysphagia and other swallowing disorders occur. In order to prepare the reader for the other articles in this publication discussing swallowing issues in depth, the authors of this article will provide a brief overview of the prevalence, risk factors, pathogenesis, clinical presentation, diagnosis, current treatment options, and implications for eating for the common forms of neurodegenerative dementias.

A First Encounter With Cognitive-Behavioral Therapies

1996 ◽  
Vol 41 (5) ◽  
pp. 475-476
Author(s):  
Arthur M. Neuz ◽  
Elizabeth A. Meadows
Keyword(s):  
Cognitive Behavioral ◽  
Behavioral Therapies ◽  
Cognitive Behavioral Therapies
Sign in / Sign up

Export Citation Format

Share Document